2017-11-09T13:58:05-06:00 2016-12-31 951777440 GREEN HASSON & JANKS LLP 10990 WILSHIRE BLVD 16TH FLOOR LOS ANGELES CA 900243929 990 2016-01-01 261636099 MELANOMA RESEARCH ALLIANCE FOUNDATION MELA 2023368935 1101 NEW YORK AVE NW NO 620 WASHINGTON DC 20005 MICHAEL KAPLAN PRESIDENT/CEO 2023368935 2017-11-09 1 LIZBETH G NEVAREZ P01399868 3108731600 38.186.35.254 2017-11-09 11:55:52 PS P F9C10BE61D25E315D3C70BCF97B7FFDFBFC33783 46B8563FC91A3595C14D3D6C677F7172A9AF6B38 2016 2018-03-14 21:41:22Z MICHAEL KAPLAN 1101 NEW YORK AVE NW NO 620 WASHINGTON DC 20005 8624499 0 X WWW.MELANOMARESEARCHALLIANCE.ORG X 2007 DE TO ACCELERATE SCIENTIFIC DISCOVERY TO ELIMINATE SUFFERING AND DEATH DUE TO MELANOMA 21 20 16 50 0 0 11318796 8445094 0 0 48679 66405 -2321 -181548 11365154 8329951 7834570 20602554 0 0 1410354 1009088 0 0 356884 1198251 988893 10443175 22600535 921979 -14270584 32895194 30882453 1021292 13389135 31873902 17493318 X TO END SUFFERING AND DEATH DUE TO MELANOMA BY COLLABORATING WITH ALL STAKEHOLDERS TO ACCELERATE POWERFUL RESEARCH, ADVANCE CURES FOR ALL PATIENTS, AND PREVENT MORE MELANOMAS. 0 0 22070095 20602554 THE MELANOMA RESEARCH ALLIANCE FOUNDATION ("MRA") SUPPORTS AMBITIOUS AND INNOVATIVE PROJECTS, INITIATED BY INDIVIDUAL SCIENTISTS AND SCIENCE RESEARCH TEAMS, TO DEVELOP NOVEL DIAGNOSTIC AND THERAPEUTIC AVENUES RELEVANT TO PATHWAYS GOVERNING THE BEHAVIOR AND CLINICAL OUTCOME OF MELANOMA. MRA CONVENES A WORLD CLASS, CROSS-DISCIPLINARY GROUP OF EXPERT BIOMEDICAL RESEARCHERS POSSESSING CLINICAL AND SCIENTIFIC EXPERTISE TO DEVELOP A RESEARCH AGENDA THAT WILL PROVIDE INNOVATIVE SOLUTIONS TO CRITICAL RESEARCH ISSUES LEADING TO BETTER TREATMENTS AND A CURE FOR MELANOMA. MRA MAKES GRANTS TO DOMESTIC RESEARCH UNIVERSITIES, MEDICAL SCHOOLS, AND NONPROFIT MEDICAL RESEARCH ORGANIZATIONS DIRECTLY INVOLVED IN DETERMINING THE CAUSES AND CURES OF MELANOMA ON THE CONDITION THAT SUCH RESEARCH BE MADE AVAILABLE TO THE SCIENTIFIC COMMUNITY. MRA ALSO MAKES GRANTS TO FOREIGN RESEARCH UNIVERSITIES, MEDICAL SCHOOLS AND MEDICAL RESEARCH ORGANIZATIONS. 22070095 1 1 0 1 0 0 0 0 0 0 1 0 0 0 0 0 1 1 0 0 1 1 0 0 1 0 0 1 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 1 X 21 0 1 16 1 0 0 0 0 0 1 1 0 0 0 0 X 21 20 1 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 0 0 AL AK AZ AR CA CO CT FL GA HI IL KS KY MA MD ME MI MN NH NJ NM NY NC ND PA OR OK OH RI SC TN UT VA WA WI WV X X MICHAEL KAPLAN 2023368935 1101 NEW YORK AVE NW 620 WASHINGTON DC 20005 DEBRA BLACK CHAIR/CO-FOUNDER 10.00 0.00 X X 0 0 0 LEON BLACK DIRECTOR/CO-FOUNDER 0.30 0.00 X 0 0 0 MARIA BELL DIRECTOR 0.30 0.00 X 0 0 0 ELLEN DAVIS DIRECTOR 0.30 0.00 X 0 0 0 JASON FEDERICI DIRECTOR 0.30 0.00 X 0 0 0 JAMI GERTZ DIRECTOR 0.30 0.00 X 0 0 0 DAISY HELMAN DIRECTOR 0.30 0.00 X 0 0 0 SUSAN HESS DIRECTOR 0.30 0.00 X 0 0 0 MICHAEL KLOWDEN DIRECTOR 0.30 0.00 X 0 572841 27740 AMANDA ELLIAN DIRECTOR 0.30 0.00 X 0 0 0 NANCY MARKS DIRECTOR 0.30 0.00 X 0 0 0 MICHAEL MILKEN DIRECTOR 0.30 0.00 X 0 0 0 RICHARD RESSLER DIRECTOR 0.30 0.00 X 0 0 0 MARY JO ROGERS DIRECTOR 0.30 0.00 X 0 0 0 JEFFREY ROWBOTTOM DIRECTOR 0.30 0.00 X 0 0 0 ELLIOTT SIGAL DIRECTOR 0.30 0.00 X 0 0 0 GREGORY SIMON DIRECTOR 0.30 0.00 X 0 0 0 JONATHAN SIMONS DIRECTOR 0.30 0.00 X 0 0 0 JONATHAN SOKOLOFF DIRECTOR 0.30 0.00 X 0 0 0 ELIZABETH STANTON DIRECTOR 0.30 0.00 X 0 0 0 SUZANNE TOPALIAN DIRECTOR 5.00 0.00 X 0 0 0 MARGARET ANDERSON SECRETARY 5.00 0.00 X 0 463048 23096 MICHAEL KAPLAN PRESIDENT & CEO (FROM 7/1/16) 40.00 0.00 X 149543 0 4990 KAMYAB HASHEMI-NEJAD TREASURER 10.00 0.00 X 0 183597 27912 ROBIN DAVISSON PRESIDENT & CEO (THROUGH 1/22/16) 10.00 0.00 X 9375 0 0 LOUISE PERKINS CHIEF SCIENCE OFFICER 40.00 0.00 X 296140 0 21920 455058 1219486 105658 2 0 1 0 0 1555710 6889384 385371 8445094 66405 66405 113000 1555710 294548 -181548 -181548 8329951 0 0 -115143 16027448 16027448 4575106 4575106 481968 289181 72295 120492 391825 303846 10648 77331 13396 8038 2009 3349 64740 48970 2188 13582 57159 40011 4573 12575 5811 4037 430 1344 23620 23620 81337 57359 2557 21421 42841 31891 1656 9294 14739 10497 1112 3130 84369 55725 6345 22299 149890 105129 11335 33426 273626 248757 2975 21894 208055 207245 216 594 25721 25721 17536 12275 1403 3858 CREDIT CARD PROCESSING 32719 22903 2618 7198 RESEARCH MATERIALS 16217 12989 861 2367 STATE FILING FEES 12412 8688 994 2730 22600535 22070095 173556 356884 3424292 2536559 18777790 20019195 10620521 8288256 43037 33604 101179 97600 29300 3579 254 1260 32895194 30882453 714723 74168 13204967 265000 110000 41569 0 1021292 13389135 X 17015455 9205062 14858447 8288256 31873902 17493318 32895194 30882453 X -14270584 -110000 X 0 1 X 1 0 X X X 1 THE MILKEN INSTITUTE 954240775 7 1 20602554 0 1 20602554 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 1 0 PART IV, SECTION A, LINE 6 THE AMOUNT OF SUPPORT REPORTED TO MILKEN INSTITUTE REPRESENTS THE AMOUNT OF FUNDS THAT MRA PAYS DIRECTLY TO RESEARCH ORGANIZATIONS LISTED ON SCHEDULES F AND I THAT SUPPORT MELANOMA RESEARCH THAT ADVANCES THE MISSION OF BOTH MRA AND THE MILKEN INSTITUTE. MRA PROVIDES DIRECT SUPPORT TO PUBLIC CHARITIES AND EDUCATIONAL INSTITUTIONS FOR THE PURPOSES OF CANCER RESEARCH SPECIFICALLY RELATED TO MELANOMA. SUPPORTING THESE UNRELATED RESEARCH ORGANIZATIONS DIRECTLY SUPPORTS THE MISSION OF THE MILKEN INSTITUTE SINCE PART OF THE INSTITUTE'S MISSION IS TO IMPROVE HEALTH WORLDWIDE. BY MRA PROVIDING THE GRANTS DIRECTLY TO THE CHARITIES AND EDUCATIONAL INSTITUTIONS, IT FURTHER ASSISTS THE MILKEN INSTITUTE. BECAUSE THERE IS A DIRECT LINE OF COMMUNICATION BETWEEN DONOR AND GRANT RECIPIENT, THE INSTITUTE CAN RELY ON MRA TO PROVIDE GRANT MONITORING AND GRANT SUPPORT SERVICES TO GRANT RECIPIENTS. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 1500 1500 22451200 22452700 1000000 250000 0 0 670199 738010 649781 1000000 3057990 4586985 4200 18000 1000 1500 24700 167550 184503 162445 250000 764498 1146747 101179 97600 3579 3579 8229951 10000 -110000 -100000 8329951 0 8329951 22610535 10000 10000 22600535 0 22600535 PART XI, LINE 2D - OTHER ADJUSTMENTS: LOSS ON WRITE-OFF OF UNCOLLECTIBLE PLEDGES RECEIVABLE -110,000. 1 MIDDLE EAST AND NORTH AFRICA 0 0 GRANTS TO RECIPIENTS LOCATED IN THE REGION 2550718 EAST ASIA AND THE PACIFIC 0 0 GRANTS TO RECIPIENTS LOCATED IN THE REGION 225000 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 GRANTS TO RECIPIENTS LOCATED IN THE REGION 1574388 NORTH AMERICA 0 0 GRANTS TO RECIPIENTS LOCATED IN THE REGION 225000 0 0 0 0 0 0 4575106 0 4575106 MIDDLE EAST AND NORTH AFRICA TEAM SCIENCE AWARD 1295836 WIRE EUROPE (INCLUDING ICELAND & GREENLAND) TEAM SCIENCE AWARD 1125000 CHECK MIDDLE EAST AND NORTH AFRICA TEAM SCIENCE AWARD 900000 WIRE NORTH AMERICA YOUNG INVESTIGATOR AWARD 225000 WIRE MIDDLE EAST AND NORTH AFRICA ESTABLISHED INVESTIGATOR AWARD 225000 CHECK EAST ASIA AND THE PACIFIC ESTABLISHED INVESTIGATOR AWARD 225000 WIRE EUROPE (INCLUDING ICELAND & GREENLAND) YOUNG INVESTIGATOR AWARD 225000 WIRE EUROPE (INCLUDING ICELAND & GREENLAND) YOUNG INVESTIGATOR AWARD 224388 WIRE MIDDLE EAST AND NORTH AFRICA TEAM SCIENCE AWARD 129882 CHECK 9 0 0 0 0 0 0 PART I, LINE 2: EACH PROPOSAL TO THE MRA IS REVIEWED FOR SCIENTIFIC MERIT AND TRANSLATIONAL AND CLINICAL IMPACT BY MRA'S WORLD-CLASS GRANT REVIEW COMMITTEE (GRC). CRITERIA ARE DESCRIBED IN THE MRA'S REQUEST FOR PROPOSALS. GRC MEMBERS ARE SENIOR THOUGHT-LEADERS IN MELANOMA AND CANCER RESEARCH. AFTER SCIENTIFIC PEER REVIEW BY THE GRC, THE MRA BOARD OF DIRECTORS APPROVES FINAL RESEARCH AWARDS FOR FUNDING. RESEARCH AWARD FUNDS ARE DISPENSED ON AN ANNUAL BASIS, CONTINGENT UPON MRA STAFF REVIEW OF ANNUAL PROGRESS REPORTS SUBMITTED BY THE GRANTEES. PART I, LINE 3: AWARDEES PROVIDE MRA WITH ANNUAL WRITTEN REPORTS OF THEIR RESEARCH PROGRESS AND COMPLIANCE WITH BUDGET GUIDELINES. FUNDS ARE DISTRIBUTED IN ANNUAL INSTALLMENTS AND NEXT YEAR'S INSTALLMENT IS NOT PROVIDED UNTIL SATISFACTORY REVIEW BY THE MRA CHIEF SCIENCE OFFICER AND SCIENTIFIC PROGRAM DIRECTOR. AWARDEES MUST KEEP SYSTEMATIC AND COMPLETE RECORDS ON THE RECEIPT AND DISBURSEMENT OF ALL AWARD FUNDS, AND MAY NOT COMMINGLE ANY FUNDS FROM OTHER SOURCES. LEVEREDGED FINANCE 1668710 1555710 113000 80652 80719 133177 1668710 1555710 113000 80652 80719 133177 294548 -181548 1 MASSACHUSETTS GENERAL HOSPITAL CUTANEOUS BIOLOGY RESEARCH CENTER BUILDING 149 3RD FLOOR CHARLESTOWN MA 02129 042697983 501 (C) (3) 2080000 TEAM SCIENCE AWARD, ESTABLISHED INVESTIGATOR AWARD THE REGENTS OF THE UNIVERSITY OF CALIFORNIA LOS ANGELES UCLA SCHOOL OF MEDICINE 52-121 CHS DEPT OF MEDICINE 10833 LE CONTE AVE LOS ANGELES CA 90095 943067788 PUBLIC UNIVERSITY 1350000 TEAM SCIENCE AWARD YALE UNIVERSITY 47 COLLEGE STREET SUITE 203 NEW HAVEN CT 06520 060646973 501 (C) (3) 1287500 YOUNG INVESTIGATOR AWARD, PILOT AWARD, TEAM SCIENCE AWARD UNIVERSITY OF PENNSYLVANIA 3451 WALNUT STREET PHILADELPHIA PA 19104 231352685 501 (C) (3) 1179789 TEAM SCIENCE AWARD, ESTABLISHED INVESTIGATOR AWARD DANA-FARBER CANCER INSTITUTE 450 BROOKLINE AVENUE D1542 BOSTON MA 02215 042263040 501 (C) (3) 1147452 INDUSTRY PARTNERSHIP AWARD, TEAM SCIENCE AWARD, YOUNG INVESTIGATOR AWARD THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISCO 1450 3RD ST HD-365 HELEN DILLER CR BLDG SAN FRANCISCO CA 94143 946036493 PUBLIC UNIVERSITY 1137208 ESTABLISHED INVESTIGATOR PARTNERSHIP AWARD, ESTABLISHED INVESTIGATOR AWARD, YOUNG INVESTIGATOR AWARD UNIVERSITY OF MICHIGAN 3003 S STATE STREET ANN ARBOR MI 48109 386006309 501 (C) (3) 1067328 YOUNG INVESTIGATOR AWARD, TEAM SCIENCE AWARD THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 630 WEST 168TH STREET BOX 49 NEW YORK NY 10032 135598093 501 (C) (3) 966667 TEAM SCIENCE AWARD, ESTABLISHED INVESTIGATOR AWARD H LEE MOFFITT CANCER CENTER 12902 MAGNOLIA DRIVE TAMPA FL 33612 592451713 500 (C) (3) 900000 TEAM SCIENCE AWARD JOHNS HOPKINS UNIVERSITY 3910 KESWICK ROAD N4327B BALTIMORE MD 21287 520595110 501 (C) (3) 675000 TEAM SCIENCE AWARD MASSACHUSETTS INSTITUTE OF TECHNOLOGY 77 MASSACHUSETTS AVENUE CAMBRIDGE MA 02139 042103594 501 (C) (3) 475000 ESTABLISHED INVESTIGATOR AWARD UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER 1515 HOLCOMBE BLVD UNIT 0904 HOUSTON TX 77030 746001118 501 (C) (3) 450000 YOUNG INVESTIGATOR AWARD ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI 1 GUSTAVE L LEVY PLACE NEW YORK NY 10029 136171197 501 (C) (3) 300000 ESTABLISHED INVESTIGATOR, YOUNG INVESTIGATOR AWARD MEMORIAL SLOAN-KETTERING CANCER INSTITUTE 1275 YORK AVENUE NEW YORK NY 10065 131924236 501 (C) (3) 300000 TEAM SCIENCE AWARD TRUSTEES OF BOSTON UNIVERSITY 881 COMMONWEALTH AVENUE BOSTON MA 02215 042103547 501 (C) (3) 300000 YOUNG INVESTIGATOR AWARD UNIVERSITY OF ILLINOIS 1901 SOUTH FIRST STREET SUITE A CHAMPAIGN IL 61820 376000511 501 (C) (3) 291000 ACADEMIC-INDUSTRIAL PARTNERSHIP AWARD BRIGHAM AND WOMEN'S HOSPITAL INC 75 FRANCIS STREET BOSTON MA 02115 042312909 501 (C) (3) 275000 YOUNG INVESTIGATOR AWARD COLUMBIA UNIVERSITY MEDICAL CENTER 630 WEST 168TH STREET NEW YORK NY 10032 135598093 501 (C) (3) 250000 AWARD OREGON HEALTH & SCIENCES UNIVERSITY 2525 SW 3RD AVENUE SUITE 245 PORTLAND OR 97201 931176109 501 (C) (3) 225000 YOUNG INVESTIGATOR AWARD UNIVERSITY OF UTAH 201 S PRESIDENTS CIRCLE ROOM 411 SALT LAKE CITY UT 84112 876000525 501 (C) (3) 225000 ESTABLISHED INVESTIGATOR AWARD HEALTH RESEARCH INC ELM CARLTON STREETS BUFFALO NY 14263 141402155 204498 AWARD JOAN & SANFORD I WEILL MC 1300 YORK AVENUE NEW YORK NY 10065 131623978 150000 AWARD THE RECTOR AND VISITORS OF THE UNIVERSITY OF VIRGINIA 101 HOSPITAL DRIVE CHARLOTTESVILLE VA 22908 546001796 500 (C) (3) 112500 ESTABLISHED INVESTIGATOR AWARD UNIVERSITY OF PITTSBURGH 5117 CENTRE AVENUE PITTSBURGH PA 15213 250965591 501 (C) (3) 100000 AWARD THOMAS JEFFERSON UNIVERSITY 233 SOUTH 10TH STREET PHILADELPHIA PA 19107 231352651 501 (C) (3) 83333 ESTABLISHED INVESTIGATOR PATNERSHIP AWARD THE UNIV OF NC AT CHAPEL HILL OFFICE OF SPONSORED RESEARCH 104 AIRPORT DRIVE SUITE 2200 CB1350 CHAPEL HILL NC 27599 566001393 501 (C) (3) 77193 AWARD BAYLOR COLLEGE OF MEDICINE ONE BAYLOR PLAZA HOUSTON TX 77030 741613878 500 (C) (3) 75000 AWARD FRED HUTCHINSON CANCER RESEARCH CENTER 1100 FAIRVIEW AVENUE N J6-500 PO BOX 19024 SEATTLE WA 98109 237156071 501 (C) (3) 75000 YOUNG INVESTIGATOR AWARD NEW YORK UNIVERSITY SCHOOL OF MEDICINE 546 FIRST AVENUE NEW YORK NY 10016 136562308 501 (C) (3) 75000 ESTABLISHED INVESTIGATOR THE REGENTS OF THE UNIVERSITY OF CALIFORNIA IRVINE 845 HEALTH SERVICES ROAD SUITE 3022 3022 IRVINE CA 92697 952226406 PUBLIC UNIVERSITY 75000 YOUNG INVESTIGATOR THE WISTAR INSTITUTE 3601 SPRUCE STREET PHILADELPHIA PA 19104 236434390 501 (C) (3) 75000 YOUNG INVESTIGATOR AWARD UNIVERSITY OF CALIFORNIA SAN DIEGO 9500 GILMAN DRIVE LA JOLLA CA 92093 956006144 PUBLIC UNIVERSITY 75000 AWARD NORTHWESTERN UNIVERSITY - CHICAGO CAMPUS 300 E SUPERIOR STREET TARRY 13-705 CHICAGO IL 60611 362167817 501 (C) (3) 50000 PILOT AWARD UNIVERSITY OF MARYLAND FOUNDATION INC 3300 METZAROTT ROAD ADELPHI MD 20783 521125883 501 (C) (3) 50000 YOUNG INVESTIGATOR AWARD THE OHIO STATE UNIVERSITY 1960 KENNY ROAD COLUMBUS OH 43210 316025986 PUBLIC UNIVERSITY 37500 YOUNG INVESTIGATOR AWARD UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION 109 KINKEAD HALL LEXINGTON KY 40506 616033693 501 (C) (3) 25000 AWARD WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH 9 CAMBRIDGE CENTER CAMBRIDGE MA 02142 061043412 501 (C) (3) 25000 YOUNG INVESTIGATOR AWARD UNIVERSITY OF CINCINNATI 3225 EDEN AVENUE 225C WHERRY HALL CINCINNATI OH 45221 316000989 501 (C) (3) 20000 YOUNG INVESTIGATOR AWARD PV DISCOUNT ON GRANTS 999999999 -239523 PV DISCOUNT ON GRANTS 34 PART I, LINE 2: EACH PROPOSAL TO THE MRA IS REVIEWED FOR SCIENTIFIC MERIT AND TRANSLATIONAL AND CLINICAL IMPACT BY MRA'S WORLD-CLASS GRANT REVIEW COMMITTEE (GRC). CRITERIA ARE DESCRIBED IN THE MRA'S REQUEST FOR PROPOSALS. GRC MEMBERS ARE SENIOR THOUGHT-LEADERS IN MELANOMA AND CANCER RESEARCH. AFTER SCIENTIFIC PEER REVIEW BY THE GRC, THE MRA BOARD OF DIRECTORS APPROVES FINAL RESEARCH AWARDS FOR FUNDING. RESEARCH AWARD FUNDS ARE DISPENSED ON AN ANNUAL BASIS, CONTINGENT UPON MRA STAFF REVIEW OF ANNUAL PROGRESS REPORTS SUBMITTED BY THE GRANTEES. ALL MRA-FUNDED INVESTIGATORS AND THEIR INSTITUTIONS MUST AGREE TO PERFORM THE RESEARCH PROPOSAL IN FULL COMPLIANCE WITH ALL APPLICABLE LAWS AND REGULATIONS, THE TERMS AND CONDITIONS OF THE MRA REQUEST FOR PROPOSALS, THE REQUIREMENTS OF THE MRA TERMS AND CONDITIONS OF THE RESEARCH PROPOSAL. AT ANY TIME DURING THE AWARD PERIOD, AWARDEES MUST NOTIFY AND MRA MUST APPROVE ANY SIGNIFICANT CHANGES TO THE RESEARCH PROPOSAL INCLUDING RESEARCH PLAN, BUDGET, AND PERSONNEL. AWARDEES PROVIDE MRA WITH ANNUAL WRITTEN REPORTS OF THEIR RESEARCH PROGRESS AND COMPLIANCE WITH BUDGET GUIDELINES. FUNDS ARE DISTRIBUTED IN ANNUAL INSTALLMENTS AND NEXT YEAR'S INSTALLMENT IS NOT PROVIDED UNTIL SATISFACTORY REVIEW BY THE MRA CHIEF SCIENCE OFFICER AND SCIENTIFIC PROGRAM DIRECTOR. AWARDEES MUST KEEP SYSTEMATIC AND COMPLETE RECORDS ON THE RECEIPT AND DISBURSEMENT OF ALL AWARD FUNDS, AND MAY NOT CO-MINGLE ANY FUNDS FROM OTHER SOURCES. X X X 0 0 0 0 0 0 0 1 0 MICHAEL KLOWDEN DIRECTOR 0 447841 0 125000 0 0 0 5300 0 22440 0 600581 0 0 MARGARET ANDERSON SECRETARY 0 328048 0 135000 0 0 0 5300 0 17796 0 486144 0 0 MICHAEL KAPLAN PRESIDENT & CEO (FROM 7/1/16) 149543 0 0 0 0 0 0 0 4990 0 154533 0 0 0 KAMYAB HASHEMI-NEJAD TREASURER 0 177097 0 6500 0 0 0 3720 0 24192 0 211509 0 0 LOUISE PERKINS CHIEF SCIENCE OFFICER 271140 0 25000 0 0 0 5300 0 16620 0 318060 0 0 0 PART I, LINE 7 EMPLOYEES WERE ELIGIBLE TO RECEIVE PERFORMANCE-BASED BONUSES. X 3 293412 PROCEEDS (SEC SALES) X 2017 LEVERAGED FINANCE EVENT 1,000 GIFT BAGS PRODUCTS 7 91959 FMV 0 1 0 PART I, COLUMN (B): NON CASH DONATIONS ARE LISTED BY TOTAL NUMBER OF DONORS. FORM 990, PART V, LINE 2A THE ORGANIZATION DOES NOT ISSUE ANY W-2S FOR THEIR EMPLOYEES. THE SUPPORTED ORGANIZATION, THE MILKEN INSTITUTE, ISSUES ALL W-2S BUT EMPLOYEE COMPENSATION IS PAID BY THE MELANOMA RESEARCH ALLIANCE ITSELF. W-2S REPORTED ARE THOSE THAT ARE ISSUED BY MILKEN INSTITUTE ON BEHALF OF MRA. FORM 990, PART VI, SECTION A, LINE 2 DEBRA BLACK AND LEON BLACK HAVE A FAMILY RELATIONSHIP. DEBRA BLACK AND RICHARD RESSLER HAVE A FAMILY RELATIONSHIP. JAMI GERTZ AND DEBRA BLACK HAVE A FAMILY RELATIONSHIP. FORM 990, PART VI, SECTION B, LINE 11B MRA'S CEO AND TREASURER JOINTLY REVIEW THE FORM 990. THE FINAL DRAFT IS MADE AVAILABLE ELECTRONICALLY TO ALL THE BOARD MEMBERS BEFORE THE CEO SIGNS THE DOCUMENT AND IT IS FILED WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C AS STATED IN THE MRA BYLAWS, EACH DIRECTOR, TRUSTEE, PRINCIPAL OFFICER, AND MEMBER OF A COMMITTEE OF THE BOARD IS TO SIGN A STATEMENT ANNUALLY AFFIRMING THEY HAVE RECEIVED THE CONFLICT OF INTEREST POLICY, THEY HAVE READ AND UNDERSTAND IT, AND THEY AGREE TO COMPLY WITH IT. UPON POTENTIAL CONFLICT OF INTERESTS, THE BOARD OR COMMITTEE WILL RESOLVE THE CONFLICT IN THE BEST INTEREST OF THE ORGANIZATION. FORM 990, PART VI, SECTION B, LINE 15A ACCORDING TO THE MRA BYLAWS, MEMBERS OF THE BOARD REVIEW AND APPROVE THE MRA CEO SALARY TO ENSURE IT IS JUST AND REASONABLE. DURING THIS ANNUAL REVIEW, MEMBERS OF THE BOARD USE THE FEDERAL FORM 990 OF OTHER ORGANIZATIONS FOR COMPARABLES. THERE ARE NO OTHER OFFICERS, DIRECTORS, OR KEY EMPLOYEES THAT ARE COMPENSATED BY MRA. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. A COPY OF THE FORM 990 AND THE FINANCIAL STATEMENTS ARE AVAILABLE ON THE ORGANIZATION'S WEBSITE. FORM 990, PART XI, LINE 9: LOSS ON WRITE-OFF OF UNCOLLECTIBLE PLEDGES RECEIVABLE -110,000. MILKEN INSTITUTE 1250 FOURTH STREET SANTA MONICA CA 90401 954240775 EDUCATIONAL, ECONOMIC RESEARCH, HEALTHCARE RESEARCH CA 501(C)(3) LINE 7 N/A 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0